Tobramycin Sulfate
1 NDC across 1 manufacturer|1 Generic,0 Brand
Tobramycin Sulfate is used to treat infectious bone diseases, central nervous system infections, bacterial eye infections, intraabdominal infections, pseudomonas infections and respiratory tract infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. In 2024, Medicare Part D spent $7 million on Tobramycin Sulfate across 13,000 claims for 5,660 beneficiaries.
Tobramycin Sulfate is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $0.83 to $0.83 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$0.83 – $0.83
per ML
7d Activity
avg +12.4% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Fresenius Kabi USA, LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Aminoglycoside Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing TOBRAMYCIN SULFATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TOBRAMYCIN 80 MG/2 ML VIAL | $0.8315 per ML | +12.45% |
Frequently Asked Questions
What is Tobramycin Sulfate used to treat?
Tobramycin Sulfate is used to treat infectious bone diseases, central nervous system infections, bacterial eye infections, intraabdominal infections, pseudomonas infections and respiratory tract infections, per the National Library of Medicine's MED-RT classification.
When did Tobramycin Sulfate become available as a generic?
FDA approved the first generic Tobramycin Sulfate (ANDA) on Jan 1, 1982.
How much does Medicare spend on Tobramycin Sulfate?
In 2024, Medicare Part D spent $7 million on Tobramycin Sulfate across 13,000 claims for 5,660 beneficiaries.
How many Tobramycin Sulfate products are on the market?
The Tobramycin Sulfate drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Tobramycin Sulfate?
NADAC reference prices for Tobramycin Sulfate range from $0.8315 to $0.8315 per ML.
Which manufacturers make Tobramycin Sulfate?
1 manufacturer lists Tobramycin Sulfate in NADAC. Ranked by number of NDCs, the largest are Fresenius Kabi USA, LLC (1).
How has the price of Tobramycin Sulfate changed recently?
Over the past 7 days, 1 Tobramycin Sulfate NDC rose and 0 fell, with a market-wide average change of +12.4%.